Corteva (CTVA) Stock Forecast & Price Target

Q: What analysts cover Corteva?

Corteva has been rated by research analysts at Argus , Bank of America , BMO Capital Markets , Citigroup , Deutsche Bank Aktiengesellschaft , JPMorgan Chase & Co. , KeyCorp , Mizuho , Morgan Stanley , New Street Research , Oppenheimer , Royal Bank Of Canada , UBS Group , Weiss Ratings , and Zacks Research in the past 90 days.

$12.46 +0.54 (+4.49%)

As of 01:59 PM Eastern

Compare

Corteva - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 23 Analyst Ratings

Sell
0

Hold
9

Buy
14

Based on 23 Wall Street analysts who have issued ratings for Corteva in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 23 analysts, 9 have given a hold rating, and 14 have given a buy rating for CTVA.

Consensus Price Target

$77.00
518.23% Upside

According to the 23 analysts' twelve-month price targets for Corteva, the average price target is $77.00. The highest price target for CTVA is $103.00, while the lowest price target for CTVA is $15.00. The average price target represents a forecasted upside of 518.23% from the current price of $12.46.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for CTVA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Corteva and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CTVA Analyst Ratings Over Time

Type	Current Forecast 10/5/25 to 10/5/26	1 Month Ago 9/5/25 to 9/5/26	3 Months Ago 7/7/25 to 7/7/26	1 Year Ago 10/5/24 to 10/5/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	14 Buy rating(s)	14 Buy rating(s)	14 Buy rating(s)	14 Buy rating(s)
Hold	9 Hold rating(s)	9 Hold rating(s)	9 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$77.00	$91.50	$88.90	$80.67
Forecasted Upside	518.23% Upside	4.24% Upside	2.41% Upside	27.31% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

CTVA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CTVA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Corteva Stock vs. The Competition

Type	Corteva	Materials Companies	Broader Market
Consensus Rating Score	2.61	2.57	2.53
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	609.78% Upside	150.47% Upside	21.53% Upside
News Sentiment Rating	Neutral News See Recent CTVA News	Neutral News	Neutral News

Recent Analyst Forecasts and Stock Ratings

Show

Rating

Upside/Downside

Action

Report Date

0 Results

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
10/2/2026	BMO Capital Markets 3 of 5 stars	Joel Jackson 4 of 5 stars	Set Target		$15.00	+16.91%
10/2/2026	Morgan Stanley 3 of 5 stars	Vincent Andrews 2 of 5 stars	Reiterated Rating	Overweight	$18.00	+43.66%
9/24/2026	Oppenheimer 3 of 5 stars	Kristen Owen 3 of 5 stars	Reiterated Rating	Outperform	$95.00	+18.29%
9/18/2026	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alexandra Yates Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$91.00	+11.55%
9/17/2026	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Salvator Tiano Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Sector Weight
9/17/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Cunningham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$86.00 ➝ $91.00	+12.15%
9/16/2026	New Street Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$95.00	+14.61%
9/16/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Spector Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$85.00 ➝ $90.00	+7.88%
9/16/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Arun Viswanathan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform	$103.00	+23.46%
8/11/2026	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Strong-Buy ➝ Hold
Get the Latest News and Ratings for CTVA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Corteva and its competitors with MarketBeat's FREE daily newsletter.
8/3/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Hold (C+) ➝ Hold (C)
8/3/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy	$101.00	+29.92%
8/3/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeffrey Zekauskas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$77.00 ➝ $83.00	+5.93%
7/20/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Byrne Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$90.00 ➝ $96.00	+10.06%
7/14/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Roberts Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$96.00 ➝ $97.00	+12.87%
6/11/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Benjamin Theurer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$84.00 ➝ $91.00	+22.00%
5/13/2026	CICC Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Outperform	$80.00 ➝ $93.00	+12.31%
5/7/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target		$95.00 ➝ $97.00	+19.27%
5/6/2026	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target		$74.00 ➝ $77.00	-5.32%
4/29/2026	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Neutral	$80.00 ➝ $90.00	+13.41%
4/21/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Sison Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$85.00 ➝ $90.00	+11.99%
4/14/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$88.00 ➝ $96.00	+15.02%
3/26/2026	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Hold	$68.00 ➝ $78.00	-6.38%
2/5/2026	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Outperform	$81.00 ➝ $86.00	+17.97%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 01:59 PM ET.

Should I Buy Corteva Stock? CTVA Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, October 2, 2026. Please send any questions or comments about these Corteva pros and cons to contact@marketbeat.com.

Corteva
Bull Case

Here are some ways that investors could benefit from investing in Corteva, Inc.:

Corteva, Inc. now operates as a pure-play crop protection company following the completion of the Vylor spinoff, a structural change that management says should improve focus, agility, and operational execution while supporting a pipeline of 12 new active ingredients, including five biological products planned for launch over the next decade.
The stock currently trades at $11.90, a significant discount to the consensus analyst target price of $91.90, suggesting substantial potential upside if the market revalues the company based on its new standalone crop protection profile rather than the combined entity.
Investors can benefit from a high dividend yield of 5.73%, which provides a steady income stream and represents a payout ratio of 47.68%, indicating that the company retains a significant portion of its earnings for reinvestment while still returning capital to shareholders.
The company demonstrated strong earnings performance in the most recent quarter, reporting $2.30 in earnings per share, which beat analysts' consensus estimates of $2.24, and set full-year 2026 guidance of $3.60 to $3.80 per share, signaling confidence in its financial trajectory.
Corteva, Inc. maintains a low beta of 0.57, meaning the stock is less volatile than the broader market, which can provide a defensive characteristic for portfolios seeking stability during periods of market uncertainty.

Corteva
Bear Case

Investors should be bearish about investing in Corteva, Inc. for these reasons:

Several U.S. states have filed a fraud lawsuit related to the Vylor spinoff, creating legal, financial, and reputational uncertainty that could weigh on investor sentiment and potentially result in significant liabilities or operational disruptions.
The stock has experienced a dramatic decline, hitting a 52-week low of $11.84 and trading down significantly from its previous close of $12.57, reflecting a sharp drop in market capitalization and investor confidence following the separation of the seed business.
Short interest has increased, with 20,671,603 shares shorted as of the latest record date, representing a 15.51% month-to-month increase, which indicates that a growing number of investors are betting against the stock's future performance.
The company's revenue for the most recent quarter was $6.38 billion, which missed analyst estimates of $6.60 billion and declined 1.2% year-over-year, suggesting potential challenges in maintaining top-line growth in the crop protection segment.
Analyst sentiment has become mixed, with some firms downgrading the stock, such as Zacks Research moving from a "strong-buy" to a "hold" rating, and Seeking Alpha publishing a report titled "Corteva: No Longer Worth Owning Post-Spinoff," indicating a lack of consensus on the long-term value proposition.

CTVA Forecast - Frequently Asked Questions

According to the research reports of 23 Wall Street equities research analysts, the average twelve-month stock price forecast for Corteva is $77.00, with a high forecast of $103.00 and a low forecast of $15.00.

23 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Corteva in the last twelve months. There are currently 9 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CTVA shares.

According to analysts, Corteva's stock has a predicted upside of 518.23% based on their 12-month stock forecasts.

Over the previous 90 days, Corteva's stock had 2 downgrades and 1 upgrade by analysts.

Corteva has been rated by research analysts at Argus, Bank of America, BMO Capital Markets, Citigroup, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., KeyCorp, Mizuho, Morgan Stanley, New Street Research, Oppenheimer, Royal Bank Of Canada, UBS Group, Weiss Ratings, and Zacks Research in the past 90 days.

Analysts like Corteva more than other "materials" companies. The consensus rating score for Corteva is 2.61 while the average consensus rating score for "materials" companies is 2.57. Learn more on how CTVA compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Corteva Recommendations

MarketBeat monitors more than a dozen sources for Corteva analyst ratings, with the most recent rating issued on 10/5/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Corteva (CTVA) Stock Forecast & Price Target